{
  "id": "08fff0e5633f7c52",
  "title": "Why IDEAYA Biosciences ( IDYA ) Is Down 5 . 2 % After Completing Enrollment In Pivotal Uveal Melanoma Trial",
  "description": "20251215T011500Z",
  "content": "",
  "source": "finance.yahoo.com",
  "source_url": "https://finance.yahoo.com/news/why-ideaya-biosciences-idya-down-001823496.html",
  "published_at": "20251215T011500Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "llm"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://finance.yahoo.com/news/why-ideaya-biosciences-idya-down-001823496.html",
    "url_mobile": "",
    "title": "Why IDEAYA Biosciences ( IDYA ) Is Down 5 . 2 % After Completing Enrollment In Pivotal Uveal Melanoma Trial",
    "seendate": "20251215T011500Z",
    "socialimage": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
    "domain": "finance.yahoo.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}